Legal Representation
Attorney
Michael G. Shariff
USPTO Deadlines
Application History
48 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Feb 25, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Feb 25, 2025 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
Jan 27, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jan 27, 2025 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
Jul 26, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
Jul 26, 2024 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
Jul 26, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jul 26, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jun 27, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jun 27, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Jun 25, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Apr 26, 2024 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
Apr 26, 2024 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
Apr 26, 2024 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
Apr 26, 2024 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
Apr 26, 2024 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
Feb 26, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
Feb 26, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Jan 26, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Jul 28, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jul 26, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Jul 26, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Jul 26, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jan 28, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jan 26, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Jan 26, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jan 26, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Jul 26, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
May 31, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
May 31, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
May 11, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Apr 25, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
Apr 22, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Apr 6, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Apr 6, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Apr 6, 2022 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
Oct 8, 2021 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
Oct 8, 2021 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
Oct 8, 2021 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
Sep 9, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Sep 9, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Sep 9, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Apr 14, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Apr 14, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Apr 14, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Apr 13, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jan 28, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Nov 26, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations and substances, used internally as pills and other solids, and also used as sprays and liquids for the treatment and prevention of killing viruses, bacteria, coronaviruses including COVID-19, SARS, biofilms, fungi, mold, and spores; Pharmaceutical preparations, namely, anti-infectives for use in or as chemotherapeutics; Pharmaceutical preparations for the treatment of viral diseases for use in or as chemotherapeutics; Disinfectants; Sanitizing preparations for household, commercial, and hospital use; All-purpose disinfectants for killing viruses, bacteria, coronaviruses including COVID-19, SARS, biofilms, fungi, mold, and spores; Nasal spray for the treatment and prevention of killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, spores
Class 011
Disinfectant apparatus for medical purposes; Disinfectant apparatus for medical purposes for killing viruses, bacteria, coronaviruses including COVID-19, SARS, biofilms, fungi, mold, and spores; Cleansing/sanitizing system comprising a containment enclosure specially adapted for containing an atomized cleansing/sanitizing spray mechanism for use in the cleansing/sanitizing of objects including articles of manufacture, natural products, foods and pharmaceuticals
Additional Information
Design Mark
The mark consists of the letter "CO" in large capital letters shaded in red and outlined in black followed by the word "Fix" in white and outlined in black with the letters "RX" dropped after the letter "x" in "Fix" with the letter "R" in red and a portion of the letter "X" in white both of which are outlined in black.
Color Claim
The color(s) red, black and white is/are claimed as a feature of the mark.
Pseudo Mark
CO FIX RX
Classification
International Classes
005
011